Clinical Trial Update: Study of the Effectiveness of Passive Immunotherapy in HIV-Infected Patients Who Are in Virologic Failure [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating passive immunotherapy in HIV-infected patients with virologic failure has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Passive immunotherapy (unspecified agent)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: HIV Infection | Phase 2, Phase 3 | Status: SUSPENDED